Frontiers in Immunology

Article	Citations
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)	1705
The COVID-19 Cytokine Storm; What We Know So Far	1132
Tumor-Associated Macrophages in Tumor Immunity	800
The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health	790
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies	772
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19	485
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies	468
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses	429
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation	421
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures	390
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19	357
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper	348
The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology	344
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment	337
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies	332
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past	330
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)	329
Targeting the NLRP3 Inflammasome in Severe COVID-19	323
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses	317
Phagocytosis: Our Current Understanding of a Universal Biological Process	310
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body	305
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens	302
Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury	295
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection	291
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes	290

Interferon-α2b Treatment for COVID-19	284
Maternal Immunological Adaptation During Normal Pregnancy	277
Interplay Between NLRP3 Inflammasome and Autophagy	272
Interaction of Microglia and Astrocytes in the Neurovascular Unit	265
Dendritic Cells and Their Role in Immunotherapy	263
The Intestinal Microbiota and Colorectal Cancer	261
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis	249
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection	246
Myeloid Cell-Derived Arginase in Cancer Immune Response	242
The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria	242
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System	240
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning	238
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis	236
NF-κB: At the Borders of Autoimmunity and Inflammation	231
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint	226
Crosstalk Between Astrocytes and Microglia: An Overview	223
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia	216
Localized Interleukin-12 for Cancer Immunotherapy	216
T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells	214
Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies	213
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases	213
Colorectal Cancer Immunotherapy: Options and Strategies	209
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns	204
Neutrophils in COVID-19	202
Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19	199
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation	193
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion	191
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions	191
Macrophages: The Good, the Bad, and the Gluttony	191
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer	190
The Role of Inflammation in Diabetic Retinopathy	188
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity	188
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance	186
Macrophage Polarization and Its Role in Liver Disease	185
Regulation of PD-L1 Expression by NF-κB in Cancer	184
Humoral Responses and Serological Assays in SARS-CoV-2 Infections	183
SARS-CoV-2 Variants, Vaccines, and Host Immunity	180
Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19	180
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19	179
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies	176
CD8+ T Cell Exhaustion in Cancer	173
Emerging Concepts and Technologies in Vaccine Development	170
Epstein-Barr Virus and Systemic Autoimmune Diseases	170
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma	168
T Cells in Fibrosis and Fibrotic Diseases	168
Severe COVID-19: NLRP3 Inflammasome Dysregulated	167
Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)	164
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape	162
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation	161
Monocytes and Macrophages in COVID-19	160

Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response	159
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers	159
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma	159
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19	157
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants	154
IL-1β and the Intestinal Epithelial Tight Junction Barrier	152
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia	152
Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach	150
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy	150
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant	149
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside	149
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies	148
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword	146
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview	146
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis	146
Reactive Oxygen Species in Macrophages: Sources and Targets	145
Adjuvants for Coronavirus Vaccines	145
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration	145
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients	144
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside	142
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment	141
COVID-19: Coronavirus Vaccine Development Updates	141
Immunosuppressive Mechanisms of Regulatory B Cells	140
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation	140
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape	140
Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?	139
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19	138
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity	138
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases	138
Multiple Roles for Chemokines in Neutrophil Biology	137
Probiotics in Medicine: A Long Debate	137
Microglia and Inflammatory Responses in Diabetic Retinopathy	136
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities	136
Genetics Insight for COVID-19 Susceptibility and Severity: A Review	136
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?	135
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19	135
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies	135
Microbiota Modulation of the Gut-Lung Axis in COVID-19	135
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond	134
The Roles of Inflammation in Keloid and Hypertrophic Scars	134
The Oral Microbiome and Cancer	134
The Immune Response and Immunopathology of COVID-19	134
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity	133
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia	133
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma	133
Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease	133
The Role of Macrophages in Staphylococcus aureus Infection	131
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches	131
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis	130
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies	130
Bispecific Antibodies: From Research to Clinical Application	128
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy	128
Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics	126
What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses	125
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects	125
IL-15 in the Combination Immunotherapy of Cancer	125
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome	125
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies	125
The Role of Natural Killer Cells in Autoimmune Diseases	124
Sex Differences in Immunity to Viral Infections	124
Protective Functions of Reactive Astrocytes Following Central Nervous System Insult	124
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis	123
Modulation of Immune Responses by Particle Size and Shape	123
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition	123
TERT—Regulation and Roles in Cancer Formation	123
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy	122
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs	122
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection	122
Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling	121
Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study	121
Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway	120
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19	120
Role of Human Milk Bioactives on Infants' Gut and Immune Health	119
Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response	119
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances	119
Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction	119
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma	118
A Bibliometric Analysis of Pyroptosis From 2001 to 2021	117
Controlling Cytokine Storm Is Vital in COVID-19	117
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?	117

Neoantigen: A New Breakthrough in Tumor Immunotherapy	117
The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals	116
Immunoglobulins, Mucosal Immunity and Vaccination in Teleost Fish	116
Research Progress in Atopic March	116
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies	116
Defensins: A Double-Edged Sword in Host Immunity	115
Digital Twins for Multiple Sclerosis	115
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People	114
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors	114
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic	114
Interleukin-17 in Chronic Inflammatory Neurological Diseases	114
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis	114
C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights	113
Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs	112
Cytokines in CAR T Cell–Associated Neurotoxicity	112
Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases	111
Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis	111
Regulation of SIRT1 and Its Roles in Inflammation	111
Immunotherapy in Lung Cancer: Current Landscape and Future Directions	110
Antigen Cross-Presentation by Macrophages	109
IDO Expression in Cancer: Different Compartment, Different Functionality?	109
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies	109
T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus	108
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies	108
Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease	108
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies	108
Astragalin Attenuates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting NF-κB Activation in Mice	107
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins	106
IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology	106
Covid-19: Perspectives on Innate Immune Evasion	106
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning	106
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease	105
IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy	105
Antibody Responses in COVID-19: A Review	105
FcγR Binding and ADCC Activity of Human IgG Allotypes	104
Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis	104
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis	103
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma	103
Causal Effects of Gut Microbiome on Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study	103
Immunogenic Cell Death Induction by Ionizing Radiation	103
Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation	103
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment	102
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces	102
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility	102
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer	102
SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1	102
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?	102
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma	102
ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis	102
Exosome-Based Vaccines: History, Current State, and Clinical Trials	102
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways	102
Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia	102
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health	101
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?	101
B7-H3/CD276: An Emerging Cancer Immunotherapy	101
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly	101
Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic	101
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair	100
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers	100
Diversity of Macrophages in Lung Homeostasis and Diseases	100
Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism	100
Obesity, Inflammation, and Immune System in Osteoarthritis	99
Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated Signaling	99
Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation	99
The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases	99
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways	98
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients	98
Immunogenicity Risk Profile of Nanobodies	98
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines	97
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases	97
Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?	96
Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse	96
Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19	94
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro	94
Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides	94
3D Tumor Models and Their Use for the Testing of Immunotherapies	94
Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment	94
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures	94
The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19	94
Increased Plasma Heparanase Activity in COVID-19 Patients	94
Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients	93
The Role of Microbiota in Infant Health: From Early Life to Adulthood	93
Alpha-2-Macroglobulin in Inflammation, Immunity and Infections	93
Interleukins and Ischemic Stroke	93
Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease	93
Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”	92
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects	92
Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.	92
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets	92
Cathelicidins Modulate TLR-Activation and Inflammation	92
MAIT Cell Activation and Functions	92
Diagnosis for Latent Tuberculosis Infection: New Alternatives	92
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries	91
Potential Implications of Quercetin in Autoimmune Diseases	91
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies	91